These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8959283)

  • 21. No differences in calcium-binding protein immunoreactivity in the posterior cingulate and visual cortex: schizophrenia and controls.
    Wheeler DG; Dixon G; Harper CG
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):630-9. PubMed ID: 16503370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors.
    Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K
    Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
    Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
    Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volumetric analysis of sulci/gyri-defined in vivo frontal lobe regions in schizophrenia: Precentral gyrus, cingulate gyrus, and prefrontal region.
    Zhou SY; Suzuki M; Hagino H; Takahashi T; Kawasaki Y; Matsui M; Seto H; Kurachi M
    Psychiatry Res; 2005 Jul; 139(2):127-39. PubMed ID: 15967647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution scatchard analysis shows D1 receptor binding on pyramidal and nonpyramidal neurons.
    Davidoff SA; Benes FM
    Synapse; 1998 Jan; 28(1):83-90. PubMed ID: 9414021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.
    Newell KA; Zavitsanou K; Jew SK; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):225-33. PubMed ID: 16901598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder.
    Thomas AJ; Davis S; Ferrier IN; Kalaria RN; O'Brien JT
    Biol Psychiatry; 2004 Mar; 55(6):652-5. PubMed ID: 15013836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
    Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
    Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoradiographic localization of dopamine D1 receptors in the human kidney.
    Ricci A; Escaf S; Vega JA; Amenta F
    J Pharmacol Exp Ther; 1993 Jan; 264(1):431-7. PubMed ID: 8423542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain dopamine d1 receptors in twins discordant for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Am J Psychiatry; 2006 Oct; 163(10):1747-53. PubMed ID: 17012685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics.
    Benes FM; Vincent SL; Alsterberg G; Bird ED; SanGiovanni JP
    J Neurosci; 1992 Mar; 12(3):924-9. PubMed ID: 1372045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.
    Ruiz J; Gabilondo AM; Meana JJ; García-Sevilla JA
    Psychopharmacology (Berl); 1992; 109(4):410-4. PubMed ID: 1365855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.
    Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):415-425. PubMed ID: 30958880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.
    Benes FM; Vincent SL; Marie A; Khan Y
    Neuroscience; 1996 Dec; 75(4):1021-31. PubMed ID: 8938738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study.
    Lahti RA; Cochrane EV; Roberts RC; Conley RR; Tamminga CA
    J Neural Transm (Vienna); 1998; 105(4-5):507-16. PubMed ID: 9720978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia.
    Deakin JF; Slater P; Simpson MD; Gilchrist AC; Skan WJ; Royston MC; Reynolds GP; Cross AJ
    J Neurochem; 1989 Jun; 52(6):1781-6. PubMed ID: 2566649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.
    Benes FM; Todtenkopf MS; Logiotatos P; Williams M
    J Chem Neuroanat; 2000 Dec; 20(3-4):259-69. PubMed ID: 11207424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia.
    Wyatt RJ; Karoum F; Casanova MF
    Biol Psychiatry; 1995 Jul; 38(1):4-12. PubMed ID: 7548471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An electrophysiological study on the effects of tryptophan and cortisol on schizophrenic and other mentally ill patient groups and on normal subjects.
    Cowen MA
    Biol Psychiatry; 1976 Aug; 11(4):389-401. PubMed ID: 986840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.